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INTRODUCTION
Uric acid is the end-product of purine catabolism in man. An .abnormal concentration of uric acid in body fluids may be indicative of a number of disturbances. An increased level of uric acid in serum (hyperuricemia) is seen in primary gout: although there is a normal excretion rate, uric acid is overproduced or it is underexcreted [I] _ In secom?ary gout, h yperuricemia might result either from increased nucIeic acid ~UEWWX (for example, hematologic disorders, ieukemia), or from decreased renal excretion of uric acid induced by drugs or dietary factors. Also in a number. of genetic disorders, sueh as glycogen storage disease, Down's syn-drome and psoriasis, is hyperuricemia a common feature [I, 23.
The methods cwrently used to assay uric acid in serum and urine are based on either chemical or enzymatic oxidation to slhmtoti. The enzymatic method seems to be the method of choice because of its sensitivity, accuracy and spa methods, the determination of uric acid by HPLC and isotache phoresis is much less hampered by iuterfering substances, such as drugs and biological metabolites. In contrast to the HPLC procedure, where pretreatment of biological samples is often necessary (e.g. removal of proteins), the sample can mostly be applied-directly in isotachophoresis. Moreover, the ratio of free to protiin-bound urate can be determined conveniently using a simple ultrafiltration step. sample constituents are tolerated and different operational systems can be applied in one analysis. Moreover different electrophoretic principles (for example, isotachophoresis and zone electrophoresis) can be applied WI -
MATERIALS AND METHODS
Uric
The enzymatic determination of serum uric acid was performed in the labsratory of the Department of Neurology (University Hospital, Nijmegen) with an ABA 100 bichromatic analyser (Abbott). The determination of uric acid is based on the successive action of three purified enzymes which are added to the reaction mixture: uricase, cat&se and aldehyde dehydrogenase [4]. The formation of NADPH from NADP+ in the latter reaction (measured at both 340 and 380 nm) is used for the quantification of uric acid. Sera containing known concentrations of uric acid were used as standards.
RESULTS
The operational conditions for the isotachophoretic determination of uric acid are listed in Table I . The leading electrolyte (pH 5.0) contains Cl -as the leading ion; the terminating ekctrolyte (pH 6.5) cork&s of morpholino-ethanesulfonic acid and Tris. The analysis time with the column coupling system is 12 min.
Physiological uric acid concentrations normally range between 0.15 and 0.40 m&f. In Fig. 1 When standard amounts of uric acid were added to senrm,ex~nsive~y didysed against 0.9% NaCl, the isotachophoretic analyses yielded recoveries of 99.0-100.5% (data not shown). The uric acid zone was ebminated after treatment of the serum with purified uricasc. In addition, over-spiking confirmed the identie of the uric acid zone.
In order to estimate the amount of uric acid bound to serum proteins under our experimental conditions, the recovery from uitrafiltered and non-&raGl-tered sampIes was compared. When undialysed pooled serum from sevcrsl healthy controls was passed through an Amicon CF 25 filter (md-wt. cut-off 25,000), 851% of the total serum uric acid was recover&l in the ultrafiltrate, indicating that in this sample approximately 15% was bound to proteins with a mokcuhu weight exceeding 25,000. The lower amount of uric acid in the ultrafiltrate as compared to non-filtered samples was not due to the CF 25 fiks when a standard solution of uric acid (474 p&f in water) was passed through it, the recovery was 99.4%. Also the effect of high pH on the bmding of urate to serum proteins was studied. The pH of normal serum samples (pH 7.2-7-4) was adjusted with NaOH to pH 10.0 and after ukafiltration the urate binding turned out to decrease to approximately 7%.
Some seruzn samples showed turbidity, as &.&ged from visual inspection, Those samples were rapidly passed through a MilEpore filter (MiUexR, 0.22 pm).
This did not affect the recoveries. Serum samples from &x healthy controls were assayed for uric acid using the isotachophoretic method and the enzymatic~ method The samples were used either directly or after ultrafi!tration. The serum uric acid vahres obtained %vith both methods showed an acceptable correlation (Table II) -. Several metabolites and drugs can interfere with the enzymatic determination of uric acid. An example is homogentisic acid. a compound which occurs in mcreamd quantities in lurine of patients with alkaptonuria, an inborn error of ammo acid metabolism 113, 14]_ When unphysiologically high amounts of homogentisic acid were added to samples, no effe& on the isotachophoretic determinations was seen. However, with the enzymatic method higher values than those actually present were recorded (Table III) .
Serum uric acid values in three initially hyperuricemic rheumatologic patients, who were treated with a number of drugs, were in close agreement when determined by both procedures (Table IV)_ None of the drugs seemed to interfere with the uric acid determination according to both methods.
DISCUSSION
The present isotachophoretic method for the determination of uric acid Zevels in serum is quantitative, reliable and reprodticible (Fig. 1) . In contrast to the general practice in HFLC [S] there is no need for deproteinisation: the _ samples can be applied directly. However, also a EPIC system without deproteinisation has been described [5] _ It should be pointed out here, that in EiPEc it is sometimes difficult to predict the retention behsviour of a given compound. In isotachcphoreais this is more predictable on the basis of the pS, values and mobilities of the compounds under study. An additional advantage of isotachophoresis over HPLC is the flexibih@ of the system: no cohnnn packing zmd equilibration is necessary if rapid swi+khing &am one ektro]yte system to anc$her is needed when different conditions have to & tested Gnce an electrolyte system has been chosen the isotachophoretic analyses can be done with very low day-today variations (< 2%). This value is lower than that obtained with the enzymatic method with a common day-today variation of 5+X+% [I51 _ At the present time the isotachophoretic serum uric acid determination-is more accurate than the enzymatic metiod, although the latter is faster when automated_
The It has also been shown that several drugs, such as sahcylates, phenylbutazone and probenecid, reduce urate binding in vitro [20]_ It should be stressed, however, that all of these studies, includiug oux own, were done under non-physiological conditions. Therefore, no conclusion can be drawn regardiug the physiological significance, especially because in viva measurements have shown that at 37% the percenfage of urate bound is small [2X] _ Homogentisic acid is a metabolite which occurs in increased quantities in the urine of alkaptonuric patients. It interferes with the enzymatic uric acid determination at 340 nm by causing lower values than those actually present to be recorded [4]_ No effect was seen with isotachophoresis in the presence of homogentisic acid, whereas increased levels were read with the enzymatic procedure carried out with the bichromatic (380 and 340 run) analyser ABA-100 (Table ID) . No attempts were made to elucidate this experimentally, but the differences might be attributed to the use of a bichromatic analyser in the present study, in contrast to a monochromatic determination at 340 nm only [4] _ A number of dmgs used in the treatment of three initially hyperuricemic patients did not interfere with any of the methods employed: the uric acid values obtained were comparable (Table IV) .
The usefulness of isotachophoresis in screening for inborn errors of purine and pyrimidine metabolism by analysing urinary bases and nucleosides has already been demonsttated [8] _ We have recently developed operational systems 'for the analysis of purine and pyrimidine nucleosides and bases in serum [22]_ For both experimental and clinical purposes an alternative analytical approach ;S opened up, such as for the pharmacokinetic analysis of drug metabolism, or in tracing the consequences of metabolic disturbances using body fluids and cell lysates.
